Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3179-3182, Vol. 66, No. 7
University of Rochester School of Medicine,
Rochester, New York 14642,1 and
The
Trudeau Institute, Saranac Lake, New York 129832
Received 9 February 1998/Returned for modification 14 March
1998/Accepted 8 April 1998
Immunization with whole Pneumocystis carinii has been
shown to protect mice from the development of P. carinii pneumonia (PCP) when they are subsequently
immunosuppressed and challenged with viable organisms. To determine
whether these results could be duplicated by using a subunit vaccine,
we examined the immunogenicity and efficacy of an immunization strategy
based on P. carinii gpA. This antigen was chosen for
study because passive immunoprophylaxis, based on gpA, has been shown
to be partially protective in various animal models of infection.
Immunization with gpA produced an anti-gpA specific antibody response
comparable to that resulting from immunization with whole organisms.
However, in contrast to immunization with whole P. carinii, which was protective, immunization with gpA did not
protect T-cell-depleted mice from the development of PCP. These
studies suggest that other antigens in addition to gpA need to be
evaluated for their role in protective immunity against P. carinii.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Immunization with Pneumocystis carinii gpA Is
Immunogenic but Not Protective in a Mouse Model of P. carinii Pneumonia
*
Corresponding author. Mailing address: University of
Rochester School of Medicine, 601 Elmwood Ave., Box 690, Rochester, NY 14642. Phone: (716) 275-5944. Fax: (716) 273-1104. E-mail:
fgig{at}uhura.cc.rochester.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»